XYNOMIC PHARMACEUTICALS HOLDINGS, INC. - FORM S-1 - EX-23.1 - CONSENT OF MARCUM LLP - June 1, 2017

Attached files

file filename
EX-10.11 - UNIT SUBSCRIPTION AGREEMENT BETWEEN THE REGISTRANT AND EARLYBIRDCAPITAL - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex10xi_bisoncap.htm
EX-10.1 - FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, EARLYBIRDCAPITAL, INC. AND EACH O - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex10i_bisoncap.htm
EX-10.8 - FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND SECURITY HOLDER - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex10viii_bisoncap.htm
EX-10.7 - AMENDED AND RESTATED UNIT SUBSCRIPTION AGREEMENT BETWEEN THE REGISTRANT, EARLYBI - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex10vii_bisoncap.htm
EX-10.4 - FORM OF ESCROW AGREEMENT BETWEEN THE REGISTRANT, CONTINENTAL STOCK TRANSFER & TR - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex10iv_bisoncap.htm
EX-10.3 - FORM OF LETTER AGREEMENT BETWEEN BISON CAPITAL HOLDING COMPANY LIMITED, OUR SPON - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex10iii_bisoncap.htm
EX-10.2 - FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex10ii_bisoncap.htm
EX-8.1 - FORM OF TAX OPINION OF HUNTER TAUBMAN FISCHER &LI LLC - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex8i_bisoncap.htm
EX-5.2 - FORM OF OPINION OF HUNTER TAUBMAN FISCHER &LI LLC - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex5ii_bisoncap.htm
EX-4.7 - FORM OF RIGHT AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND T - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex4vii_bisoncapital.htm
EX-4.6 - FORM OF UNIT PURCHASE OPTION BETWEEN THE REGISTRANT AND EARLYBIRDCAPITAL, INC. - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex4vi_bisoncapital.htm
EX-4.5 - FORM OF WARRANT AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex4v_bisoncapital.htm
EX-4.4 - SPECIMEN RIGHT CERTIFICATE - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex4iv_bisoncapital.htm
EX-4.3 - SPECIMEN WARRANT CERTIFICATE - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex4iii_bisoncapital.htm
EX-4.1 - SPECIMEN UNIT CERTIFICATE - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex4i_bisoncapital.htm
EX-1.2 - LETTER AGREEMENT BETWEEN THE REGISTRANT AND EARLYBIRDCAPITAL - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex1ii_bisoncapital.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017ex1i_bisoncapital.htm
S-1 - REGISTRATION STATEMENT - XYNOMIC PHARMACEUTICALS HOLDINGS, INC.fs12017_bisoncapital.htm

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Registration Statement of Bison Capital Acquisition Corp. (the “Company”) on Form S-1 of our report dated February 28, 2017, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of Bison Capital Acquisition Corp. as of December 31, 2016 and for the period from October 7, 2016 (inception) through December 31, 2016, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

 

/s/ Marcum llp  

Marcum llp

New York, NY

May 31, 2017

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Reports